Mashup Media and The Oncology Brothers Announce Partnership
MANALAPAN, N.J. (PRWEB) February 16, 2023 — This collaboration will expand the reach of impactful, community-based oncology content
Related Articles
Re-treating Locally Recurrent PCa With EBRT Is Feasible | GU Oncology Now
A recent prospective study examined the use of focal salvage reirradiation using external beam radiotherapy to determine its efficacy and feasibility.
Characterizing Benefit in Responders in the CheckMate 901 Trial | GU Oncology Now
Drs. Ambinder and Sonpavde provide an update for CheckMate 901, characterizing treatment benefit in responders.
Carboplatin, PD-1 Inhibitors Preferred Over Cisplatin-Based Regimens for aUC in New Study | GU Oncology Now
A new study recorded data on the type of treatment received in each line of therapy for advanced urothelial carcinoma, as well as the attrition…
The Uromigos Episode 313: APCCC 2024 Debate – Radiation Therapy in Advanced Disease | GU Oncology Now
Drs. Thomas Zilli and Pierre Blanchard join The Uromigos at APCCC 2024 to debate the use of radiation therapy in prostate cancer and oligometastatic disease.
Urinary Genomic Profiling for Detection, Molecular Staging of UTUC | GU Oncology Now
Drs. Murray and Broenimann highlight and evaluation of urinary genomic profiling for detection and molecular staging of UTUC.
TROP-2: Prognostic Significance for Penile Squamous Cell Carcinoma? | GU Oncology Now
A study to determine the potential utility of ADCs targeting TROP-2 in both localized PSCC and distant metastases.
Genomic Signatures Associated With Adverse Pathologic Features at RP | GU Oncology Now
Dr. Li highlights the significance of adverse pathologic features at radical prostatectomy for AS-eligible patients.
Enzalutamide Plus LuPSMA Improves PFS in mCRPC | GU Oncology Now
Enzalutamide and lutetium-177–labeled prostate-specific membrane antigen-617 have both been proven to improve OS rates in patients with mCRPC.
RCC Patient Selection, Counseling, and Improved Biomarkers, Imaging | GU Oncology Now
Drs. Joyce and Psutka consider patient counseling for adjuvant RCC therapy, and biomarkers and imaging before treatment.
The Uromigos Episode 312: APCCC 2024 – Radiation Therapy After Surgery for Prostate Cancer | GU Oncology Now
Brian and Tom speak with Drs. Piet Ost and Jason Efstathiou at ASCCC 2024 to discuss the data for and against the use of radiation…